Yve T. Huttenbach

Jan 7, 2025 | digitalcommons.library.tmc.edu | Gabriel Torrealba-Acosta |Jennifer Martin |Yve T. Huttenbach |Catherine Garcia

Keywords2019-nCoV Vaccine mRNA-1273, COVID-19 Vaccines, Encephalitis, Humans, Myoclonus, Sweet SyndromeAbstractA patient presented with fever, generalised rash, confusion, orofacial movements and myoclonus after receiving the first dose of mRNA-1273 vaccine from Moderna. MRI was unremarkable while cerebrospinal fluid showed leucocytosis with lymphocyte predominance and hyperproteinorrachia.